Search for Stocks Search for IPO Search for Indices

Customer Portal

EMI Card

Download

Offers

BAJAJ FINSERV DIRECT LIMITED

Open Your FREE Demat Account Now!

Apply Now

Fundamentals Financials Shareholding About Company Peer Comparison Latest News FAQs

Decipher Labs Ltd. Share Price

NSE

BSE

BSE : 524752

Sector : Healthcare

N/A

indicator

1D

1M

3M

6M

1Y

5Y

empty graph

Price Summary

Previous Close	₹5.98
Day's Range	₹5.98 - ₹6.29
Open	₹6.29
52 Week Range	₹05.00 - ₹11.20
Volume	1,254
Market Cap	₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs)	0.07
Market Cap (₹ in Mn)	0.00
Dividend Yield(%)	0.00
Price/Earning (TTM)	0.00
TTM EPS (₹)	-3.03
P/E Ratio	0.00
Book Value(₹)	0.33
PAT Margin (%)	-22.47
Face Value (₹)	10.00
ROCE(%)	-28.39

Financials

Particulars	QTR FY (₹ in Millions)	Annual FY (₹ in Millions)
Net sales	29.24	226.12
Expenses	N/A	N/A
PBT	-34.22	-63.86
Operating profit	0.0	0.0
Net profit	-34.27	-50.8

Shareholding Pattern

Promoters (% Holding)

16.43%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

83.57%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.00%

About Decipher Labs Ltd.

Founded	1986

Latest News

Sep

15

2026

EQUITY Posted on Sep 15^th 2026

Aurobindo Pharma informs about press release

Aurobindo Pharma has informed that it enclosed a copy of the Press Release that is being issued by the Company in connection with receipt of USFDA Final approval for Beclomethasone Dipropionate HFA Inhalation Aerosol, 40 mcg and 80 mcg.

The above information is a part of company’s filings submitted to BSE.

Read More

Sep

15

2026

EQUITY Posted on Sep 15^th 2026

Krishna Institute of Medical Sciences submit analyst meet intimation

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Krishna Institute of Medical Sciences has informed that the details of the proposed schedule of the Analyst/ Institutional Investor Meeting on September 21, 2026.

The above information is a part of company’s filings submitted to BSE.

Read More

Sep

15

2026

EQUITY Posted on Sep 15^th 2026

Boston Commerce informs about press release

Boston Commerce has informed that it enclosed Newspaper Clipping Advertisement published on 13th September, 2026 for Notice of the Annual General Meeting of the Company scheduled to be held on Wednesday, 30th September, 2026 at 5:00 P.M. (IST) through Video Conferencing Facility / Other Audio Visual Means (VC/OAVM) specifying therein the details pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, e-voting facility given by the Company pursuant to Section 108 of the Companies Act, 2013 and the Rules made thereunder. The Company has published an advertisement for which clipping of the Newspaper is attached and the same is also available on the website of the Company. This is in due compliance with the relevant Regulations of the SEBI (LODR) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Read More

Sep

15

2026

EQUITY Posted on Sep 15^th 2026

Syschem India informs about trading window closure

Syschem India has informed that in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, (PIT Regulations) and as per the Company's ‘Code of Conduct’, the trading window for dealing in the securities of the Company shall remain closed for Directors/officers/Designated Persons and their immediate relatives as defined under the PIT Regulations and the said code, from Thursday, 1 October, 2026 till the expiry of 48 (forty-eight) hours after the announcement of unaudited financial results of the company for the quarter ended on 30 September, 2026. The dates of the meeting of the Board of Directors of the Company, to approve the unaudited financial results of the Company for the quarter ended 30th September, 2026 will be intimated in due course.

The above information is a part of company’s filings submitted to BSE.

Read More

Sep

15

2026

EQUITY Posted on Sep 15^th 2026

AstraZeneca Pharma India informs about resignation of senior management personnel

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), AstraZeneca Pharma India has informed that Dr. Sandeep Arora, Director – Medical Affairs, Biopharmaceutical Business Unit and Rare Disease Business Unit, of the Company has decided to pursue a career outside the organization. Dr. Arora will complete his handover period and be relieved from duties by the close of business hours on September 15, 2026. The company has wished all the best for his future endeavors. A copy of the resignation letter is enclosed as Annexure – A. The Company is in the process of looking for a suitable replacement for this position. This being Senior Management Personnel position in terms of the SEBI Listing Regulations, it has enclosed the details as required under the SEBI Circular No. HO/49/14/14(7)2025 - CFD-POD2/I/3762/ 2026 dated January 30, 2026, attached as Annexure – B.

The above information is a part of company’s filings submitted to BSE.

Read More

Sign in to Unlock Offers!

STEP 1/2

Open Demat Account today!

Mobile Number

Enter mobile number

Frequently Asked Questions

What is the current share price of Decipher Labs Ltd. ?

The current share price of Decipher Labs Ltd. is ₹5.98 as of 2026-09-15.

What is the Market Cap of Decipher Labs Ltd. Share?

The market capitalisation of Decipher Labs Ltd. is ₹6.04 as of 2026-09-11.

What is a 1 year return for Decipher Labs Ltd. ?

The 1-year return of Decipher Labs Ltd. is -4.40% as of 2025-09-12.

What is the P/E Ratio of Decipher Labs Ltd. Share?

The P/E ratio of Decipher Labs Ltd. is 0.00 as of 2026-09-15.

What is the 52 Week High and Low of Decipher Labs Ltd. ?

The 52-week high and low of Decipher Labs Ltd. are ₹11.20 and ₹5.00, respectively, as of 2026-09-15.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.

STEP 1/2

Open a Demat Account today!

Mobile Number Enter Valid Mobile Number

Indices : Nifty 50 Nifty Bank Nifty Financial Services Nifty Next 50 Nifty Midcap 100 BSE Sensex India Vix

Stocks : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Home

Shopping

Loan Offers

My Accounts

Explore